INOVIO to Participate in Upcoming Scientific Conference
Rhea-AI Summary
INOVIO (NASDAQ: INO) will present at the World Federation of Hemophilia World Congress in Kuala Lumpur on April 22, 2026. The company will deliver a talk on DNA-Encoded Protein (DPROT) production of functional FVIII and a poster on non-viral DNA medicine FVIII expression in Hemophilia A mice.
Presentations are scheduled at 9:45 AM MYT (talk) and 10:45 AM MYT (poster). According to the company, abstracts will be posted on INOVIO's website after the presentations.
Positive
- None.
Negative
- None.
News Market Reaction – INO
On the day this news was published, INO declined NaN%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
World Federation of Hemophilia World Congress (
- Presentation: Next Gen Protein Replacement Therapeutics: DNA-Encoded Protein (DPROT) Technology Demonstrates in vivo Production of Functional FVIII in Mouse Model
Date: Wednesday, April 22
Time: 9:45 AM MYT
- Poster Presentation: FVIII Expression Via Non-viral Vector DNA Medicine Platform Results in Efficacious Levels of FVIII Protein and Correction of the Bleeding Phenotype in Hemophilia A Mice
Date: Wednesday, April 22
Time: 10:45 AM MYT
Available abstracts will be shared on INOVIO's website following presentations.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-scientific-conference-302731455.html
SOURCE INOVIO Pharmaceuticals, Inc.
FAQ
When will INOVIO (INO) present at the World Federation of Hemophilia World Congress in 2026?
What topics will INOVIO (INO) cover at the April 22, 2026 conference presentations?
Where can investors find INOVIO (INO) abstracts from the April 22, 2026 presentations?
What time are INOVIO's (INO) two presentations on April 22, 2026 at WFH World Congress?
How does INOVIO (INO) describe the Hemophilia A preclinical results presented on April 22, 2026?
